International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 2021

International Symposium on HIV and Emerging Infectious Diseases (ISHEID) is organized by Overcome and will be held from Feb 02 - 04, 2021 at Convention Center Palais des Papes, Avignon, Provence-Alpes-Cote d Azur, France.

Professions:
• Hospital and city doctors
• PU-PH
• Clinicians
• Pharmacists
• Young investigators and researchers
• Internal and external
• Paramedics: nurses and laboratory technicians

Course Description:
ISHEID 2021 dedicates a privileged place to state-of-the-art presentations, as well as to debates among experienced and younger investigators regarding new data and their implications.

This event has invited lectures by European and international leaders, many oral abstract and poster presentations, and educational workshops, as well as overviews of comorbidities by specialists of each field.

The understanding of HIV and hepatitis infections continues to grow rapidly, especially regarding our ability to develop novel prevention and therapeutic strategies that will lead to the reduction of new infections. The burden of non-communicable diseases in HIV infected subjects implicates a multidisciplinary approach of the infection and the need of close interactions with specialists from other disciplines.

ISHEID 2021 will present the latest basic research news that finds clinical applications. The congress will also present a multidisciplinary approach to infection, integrating specialized discussions with specialists from other disciplines.

ISHEID 2021 will allow all participants to have a synthetic vision of international news on HIV, hepatitis and emerging infectious diseases.

ISHEID 2021 will offer clinical practice workshops, in the form of workshops. The following themes will be addressed: PrePs, STDs, patient / expert relationships, HIV and adolescents.

It is unique in its approach, as it engages basic scientists and clinicians from the HIV, hepatitis and emerging infectious diseases fields, as well as leading scientists involved in comorbidities.

Additional details will be posted as soon as information is available.